Hepatitis B virus prevalence in three university students in Timor-Leste
Keywords:
enzyme-linked immunosorbent assay (ELISA), hepatitis B, Timor Leste, university student, virus prevalenceAbstract
Hepatitis B is a deadly and contagious disease that knows no age,both children, adults and the elderly. Timor-Leste is one of the newly independent countries within 20 years, however, in terms of infectious diseases, one of which is hepatitis B, in this youngest country it has been categorized with a high endemicity of 8.5%- 12.4% (Silva, 2017). Thus, it is necessary to anticipate so that the prevalence of hepatitis B does not continue to rise, and immediately take early prevention for the younger generation in the country of Timor-Leste, therefore one way is to carry out early detection of hepatitis B in students with the aim of knowing the presence or absence of infection. hepatitis B virus in a person's body. Thus, it can provide recommendations to the government to prevent it by vaccinating all future generations. The main reason for early detection of medical and health science students at the three universities is to prevent horizontal transmission of the hepatitis B virus in Timor-Leste. This study aims to determine the prevalence of hepatitis B virus infection and risk factors for hepatitis B virus infection in students of the Faculty of Medicine and Health Sciences from three universities in Timor-Leste.
Downloads
References
Ahmad, I., Mahsud, M. A. J., Hussain, J., Khan, M. H., Khan, H., Noman, N., ... & ud Din, S. (2010). Willingness of Medical Students for Hepatitis B & C Screening. Gomal Journal of Medical Sciences, 8(2).
Aini, R., & Susiloningsih, J. (2013). Risk Factor Associated with Hepatitis B Incidence in Pondok Pesantren Putri Ibnul Qoyyim Yogyakarta. Sains Medika, 5(1), 30-33.
Anderson, M., Choga, W. T., Moyo, S., Bell, T. G., Mbangiwa, T., Phinius, B. B., ... & Gaseitsiwe, S. (2018). Molecular characterization of near full-length genomes of hepatitis B virus isolated from predominantly HIV infected individuals in Botswana. Genes, 9(9), 453.`
Bonita, R., Beaglehole, R., & Kjellström, T. (2006). Basic epidemiology. World Health Organization.
Hamblin, C., Barnett, I. T. R., & Hedger, R. S. (1986). A new enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against foot-and-mouth disease virus I. Development and method of ELISA. Journal of immunological methods, 93(1), 115-121. https://doi.org/10.1016/0022-1759(86)90441-2
Jefferies, M., Rauff, B., Rashid, H., Lam, T., & Rafiq, S. (2018). Update on global epidemiology of viral hepatitis and preventive strategies. World journal of clinical cases, 6(13), 589.
Kember, D. (1997). A reconceptualisation of the research into university academics' conceptions of teaching. Learning and instruction, 7(3), 255-275. https://doi.org/10.1016/S0959-4752(96)00028-X
Kokkinos, C. M., Antoniadou, N., & Markos, A. (2014). Cyber-bullying: An investigation of the psychological profile of university student participants. Journal of Applied Developmental Psychology, 35(3), 204-214. https://doi.org/10.1016/j.appdev.2014.04.001
Li, A. J., Peiris, T. S. R., Sanderson, C., Lochlainn, L. N., Mausiry, M., & Ogbuanu, I. U. (2019). Opportunities to improve vaccination coverage in a country with a fledgling health system: Findings from an assessment of missed opportunities for vaccination among health center attendees—Timor Leste, 2016. Vaccine, 37(31), 4281-4290. https://doi.org/10.1016/j.vaccine.2019.06.041
Manzaba, F. D. M., & Rodríguez, M. A. Y. (2021). The technological revolution and its impact on current education: educational response to COVID-19. International Research Journal of Management, IT and Social Sciences, 8(1), 83-90. https://doi.org/10.21744/irjmis.v8n1.1090
Mast, E. E., Alter, M. J., & Margolis, H. S. (1999). Strategies to prevent and control hepatitis B and C virus infections: a global perspective. Vaccine, 17(13-14), 1730-1733. https://doi.org/10.1016/S0264-410X(98)00415-0
Mohd Hanafiah, K., Groeger, J., Flaxman, A. D., & Wiersma, S. T. (2013). Global epidemiology of hepatitis C virus infection: new estimates of age?specific antibody to HCV seroprevalence. Hepatology, 57(4), 1333-1342.
Perz, J. F., Armstrong, G. L., Farrington, L. A., Hutin, Y. J., & Bell, B. P. (2006). The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. Journal of hepatology, 45(4), 529-538. https://doi.org/10.1016/j.jhep.2006.05.013
Qian, G., Wang, L., Wu, Y., Zhang, Q., Sun, Q., Liu, Y., & Liu, F. (2009). A monoclonal antibody-based sensitive enzyme-linked immunosorbent assay (ELISA) for the analysis of the organophosphorous pesticides chlorpyrifos-methyl in real samples. Food Chemistry, 117(2), 364-370. https://doi.org/10.1016/j.foodchem.2009.03.097
Schweitzer, A., Horn, J., Mikolajczyk, R. T., Krause, G., & Ott, J. J. (2015). Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. The Lancet, 386(10003), 1546-1555. https://doi.org/10.1016/S0140-6736(15)61412-X
Silva, H. D. (2009). Risk factors of hepatitis B among blood donors in Timor Leste (Doctoral dissertation, Universitas Gadjah Mada).
Solomon, O., Mahafroz, K., Mashor, M., Arome, F., & Neha, D. (2014). Prevalence of HBV and HIV among students and staffs at the University of Jos, Nigeria: Results from a medical outreach screening program. International Journal of Scientific and Research Publications, 4(11), 2250-3153.
Spearman, C. W., Afihene, M., Ally, R., Apica, B., Awuku, Y., Cunha, L., ... & Sonderup, M. W. (2017). Hepatitis B in sub-Saharan Africa: strategies to achieve the 2030 elimination targets. The lancet gastroenterology & hepatology, 2(12), 900-909.
Stockdale, A. J., Kreuels, B., Henrion, M. Y., Giorgi, E., Kyomuhangi, I., de Martel, C., ... & Geretti, A. M. (2020). The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis. Journal of hepatology, 73(3), 523-532. https://doi.org/10.1016/j.jhep.2020.04.008
Thyagaraju, N. (2016). Water pollution and its impact on environment of society. International Research Journal of Management, IT and Social Sciences, 3(5), 1-7. Retrieved from https://sloap.org/journals/index.php/irjmis/article/view/360
Trépo, C., Chan, H. L., & Lok, A. (2014). Hepatitis B virus infection. The Lancet, 384(9959), 2053-2063. https://doi.org/10.1016/S0140-6736(14)60220-8
WHO. (2010). Prevalensi Infeksi Virus Hepatitis B, Regional Strategy for the Prevention and Control of Viral Hepatitis, Regional office for South East Asia. 25 juni 2015
WHO. (2012). Guidance on Prevention of viral Hepatitis B and C among People who inject drugs, WHO Document Production Services, Geneva, Switzerland.
WHO. (2015). Global Hepatitis Report 2017, Epidemiological Update, Increasing Mortality Calls for Actions
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health & medical sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health & Medical Sciences (IJHMS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHMS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHMS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
